# Organon to acquire Alydia Health after Merck spinoff

Merck announced that after its planned spinoff of Organon, Organon will acquire Alydia Health, a medical device company focused on postpartum hemorrhage. The transaction is expected to close after the spinoff. Financial terms were not disclosed.

- Type: Acquisition
- Announced: 2021-03-30
- Where: United States
- Status: announced
- Products: Jada System for postpartum hemorrhage
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Merck](https://endata.com/companies/1841.md)
- [Organon](https://endata.com/companies/54113.md) (acquirer)
- [Alydia Health](https://endata.com/companies/54114.md) (target)

## Sources

- [organon.com](https://www.organon.com/news/merck-announces-acquisition-of-alydia-health-on-behalf-of-its-planned-spinoff-of-organon/), 2021-03-30: "Merck and Alydia Health announced today that they have entered into a definitive agreement pursuant to which, after the intended Merck spinoff of Organon, Organon will acquire Alydia Health."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.